Rare Robotic Surgery Performed to Treat Woman with Pancreatic Tail Tumour

Mauritius women with a pancreatic tail tumor were successfully treated with complex robotic surgery in Delhi-NCR.

According to the Fortis Memorial Research Institute in Gurugram, a whole-body PET CT scan was conducted on presentation.

Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.

‘Mauritius woman underwent a 'robotic distal pancreatectomy with splenectomy' in Gurugram to remove the tumor, which was four centimeters in size. ’

It revealed that, in addition to large uterine fibroids (eight centimeters in size), there was a mass on the tail of the pancreas - an uncommon and rare occurrence.

An endoscopic ultrasound-guided needle biopsy confirmed that the tumor was benign. However, it had to be removed as it had the potential to become malignant.

"The surgery of the pancreatic tail tumor is one of the most complex robotic surgeries. Most patients who undergo this surgery are prone to developing complications," Dr. Niranjan Naik, Director Surgical Oncology, Fortis Memorial Research Institute, said in a statement.

Disrupting Glutamine Metabolism Aids to Treat Chemotherapy Resistant Pancreatic Cancer
Pancreatic cancers are resistant to chemotherapy; however, a new research has identified that targeting glutamine metabolism enhances the efficacy of chemotherapeutic drugs to treat the disease.

Up to 4 percent of patients have the risk of mortality, one of the highest in the world.

"We conducted two surgical procedures in the same general anesthesia in one sitting - a distal pancreatectomy with splenectomy and a total abdominal hysterectomy," Naik added.

Pancreatic Cancer: Bacteria on Tumors Affect Immunity and Survival of Patients
Bacteria on tumors can affect immune response and survival of patients with pancreatic cancer. The tumor microbiome can be altered by fecal microbiota transplantation (FMT), which leads to better outcomes.

Both the surgical procedures were managed robotically through a few tiny keyholes.

"Our approach worked, and the patient has recovered well without any post-operative complications," Naik said.

Immune-boosting Compound Enhances Immunotherapy Against Pancreatic Cancer
An immune-boosting compound increases the efficacy of immunotherapy against pancreatic cancer. The new drug promotes the killing of the cancer cells, resulting in the reduction of tumor size and longer life span.

According to the hospital, pancreatic tumors can form within the pancreas' head, body, and tail. Most of these tumors are malignant or have malignant potential.

"The patient has recovered well, and there have been no post-operative complications," said Dr. Ritu Garg, Zonal Director, Fortis Memorial Research Institute.

Source-IANS